SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-009694
Filing Date
2015-11-05
Accepted
2015-11-05 16:36:41
Documents
15
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vktx-10q_20150930.htm 10-Q 1685343
2 EX-10.1 vktx-ex101_298.htm EX-10.1 823439
3 EX-31.1 vktx-ex311_6.htm EX-31.1 8035
4 EX-31.2 vktx-ex312_7.htm EX-31.2 8029
5 EX-32.1 vktx-ex321_8.htm EX-32.1 9512
6 GRAPHIC g201511052101122731601.jpg GRAPHIC 53507
7 GRAPHIC g201511052101139911603.jpg GRAPHIC 2608
8 GRAPHIC g201511052101123511602.jpg GRAPHIC 2608
9 GRAPHIC g201511052101150071604.jpg GRAPHIC 2608
  Complete submission text file 0001564590-15-009694.txt   7735722

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT vktx-20150930.xml EX-101.INS 1664914
11 XBRL TAXONOMY EXTENSION SCHEMA vktx-20150930.xsd EX-101.SCH 43755
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vktx-20150930_cal.xml EX-101.CAL 39893
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vktx-20150930_def.xml EX-101.DEF 144125
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE vktx-20150930_lab.xml EX-101.LAB 346430
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vktx-20150930_pre.xml EX-101.PRE 270737
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37355 | Film No.: 151201248
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences